FDA approves another blood test for colon cancer screening
Jul 29, 2024
Currently, colonoscopy is the gold standard test for colon cancer, but adherence to it is low because it is invasive and preparation for the test is daunting.
Hormone-modulating therapy may reduce dementia risk in breast cancer
Jul 25, 2024
The greatest reduction was seen for women aged 65 to 74 years who self-identify as Black.
Chemo tied to gut microbiome changes and associated cognitive decline
Jul 23, 2024
The findings were independent of chemotherapy-induced inflammation.
Many breast cancer survivors with indications for genetic testing do not receive it
Jul 23, 2024
The findings were not just following diagnosis but six years after diagnosis.
Racial differences seen in financial hardship among older cancer survivors
Jul 01, 2024
Income and area-level disadvantage are the largest contributors to racial differences.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.